Skip to main content
. 2020 Jul 20;8(3):397. doi: 10.3390/vaccines8030397

Table 2.

Prevalent changes observed within uBCELs in SARS-CoV-2. Occurrence and geotemporal data is provided for residue variants found in ≥2 isolates.

uBCEL Change(s) n Date of First Isolation Geolocation
uBCEL-S2 I68- 11 15/03/2020 USA: WA
N74K 2 20/01/2020 Brasil; China
D80Y 2 31/03/2020 USA: WA
uBCEL-S5 G476S 7 10/03/2020 USA: WA
V483A 11 05/03/2020 USA: WA
uBCEL-S7 Q677H 2 19/03/2020 USA: UT
uBCEL-S8 T791I 6 26/02/2020 Taiwan
BCEH-E1 P71L 2 19/03/2020 USA: WA
uBCEL-N2 P67S 2 17/03/2020 USA: NY; USA: WA
uBCEL-N3 A152S 2 13/03/2020 USA: UT
uBCEL-N4 S180I 2 31/03/2020 USA: WA
S183Y 4 17/03/2020 USA
R185C 5 15/03/2020 USA
R185L 2 19/03/2020 USA
S188L 3 18/03/2020 USA
S188P 2 13/03/2020 Taiwan
S190I 3 17/03/2020 USA: NY
S196L 6 29/02/2020 USA
S197L 17 26/02/2020 Greece; Spain; USA
S202N 7 30/01/2020 China; USA
R203K,G204R 62 27/02/2020 Czech Republic; Greece; India; Israel; Peru; Spain;
Sri Lanka; Taiwan; USA
T205I 10 29/01/2020 China; USA
A208G 4 16/03/2020 USA: WA; USA: NY
uBCEL-N7 P344S 2 ?/01/2020 Japan
uBCEL-N8 E367- 2 16/03/2020 SA: UT; USA: WA